Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 91678A107 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| Norges Bank 13G/A Amendment 1 | 7.7% |
8/12/2026
Event 6/30/2026
|
|
| BlackRock, Inc. 13G | 5.2% |
7/30/2026
Event 6/30/2026
|
|
|
Decheng Capital Global Life Sciences Fund IV, L.P.
13G/A
Amendment 1
|
5.0% |
5/15/2026
Event 3/31/2026
|
|
| Decheng Capital Global Life Sciences Fund IV, L.P. | 5.0% | ||
| Decheng Capital Management IV (Cayman), LLC | 5.0% | ||
| Decheng Capital Global Healthcare Fund (Master), LP | 0% | ||
| Decheng Capital Global Healthcare GP, LLC | 0% | ||
| Xiangmin Cui | 5.0% | ||
|
TCG Crossover GP I, LLC
13G/A
Amendment 1
|
3.9% |
11/14/2025
Event 9/30/2025
|
|
| TCG Crossover GP I, LLC | 3.9% | ||
| TCG Crossover Fund I, L.P. | 3.9% | ||
| Chen Yu | 3.9% | ||
| HBM Healthcare Investments (Cayman) Ltd. 13G/A Amendment 1 | 4.1% |
11/14/2025
Event 9/30/2025
|
|
| Norges Bank 13G | 5.3% |
10/24/2025
Event 9/30/2025
|
|
|
FMR LLC
13G/A
Amendment 2
|
14.8% |
8/6/2025
Event 6/30/2025
|
|
| FMR LLC | 14.8% | ||
| Abigail P. Johnson | 14.8% | ||
|
Decheng Capital Global Life Sciences Fund IV, L.P.
13G
|
6.1% |
2/14/2025
Event 12/31/2024
|
|
| Decheng Capital Global Life Sciences Fund IV, L.P. | 5.8% | ||
| Decheng Capital Management IV (Cayman), LLC | 5.8% | ||
| Decheng Capital Global Healthcare Fund (Master), LP | 0.4% | ||
| Decheng Capital Global Healthcare GP, LLC | 0.4% | ||
| Xiangmin Cui | 6.1% | ||
|
TCG Crossover GP I, LLC
13G
|
5.2% |
2/14/2025
Event 12/31/2024
|
|
| TCG Crossover GP I, LLC | 5.2% | ||
| TCG Crossover Fund I, L.P. | 5.2% | ||
| Chen Yu | 5.2% | ||
| HBM Healthcare Investments (Cayman) Ltd. 13G | 5.1% |
2/13/2025
Event 12/31/2024
|
|
|
FMR LLC
13G/A
Amendment 1
|
13.4% |
2/12/2025
Event 12/31/2024
|
|
| FMR LLC | 13.4% | ||
| Abigail P. Johnson | 13.4% |